BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 16324111)

  • 1. An initial investigation of spinal mechanisms underlying pain enhancement induced by fractalkine, a neuronally released chemokine.
    Milligan E; Zapata V; Schoeniger D; Chacur M; Green P; Poole S; Martin D; Maier SF; Watkins LR
    Eur J Neurosci; 2005 Dec; 22(11):2775-82. PubMed ID: 16324111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence that exogenous and endogenous fractalkine can induce spinal nociceptive facilitation in rats.
    Milligan ED; Zapata V; Chacur M; Schoeniger D; Biedenkapp J; O'Connor KA; Verge GM; Chapman G; Green P; Foster AC; Naeve GS; Maier SF; Watkins LR
    Eur J Neurosci; 2004 Nov; 20(9):2294-302. PubMed ID: 15525271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) distribution in spinal cord and dorsal root ganglia under basal and neuropathic pain conditions.
    Verge GM; Milligan ED; Maier SF; Watkins LR; Naeve GS; Foster AC
    Eur J Neurosci; 2004 Sep; 20(5):1150-60. PubMed ID: 15341587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New evidence for the involvement of spinal fractalkine receptor in pain facilitation and spinal glial activation in rat model of monoarthritis.
    Sun S; Cao H; Han M; Li TT; Pan HL; Zhao ZQ; Zhang YQ
    Pain; 2007 May; 129(1-2):64-75. PubMed ID: 17123734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrathecal minocycline attenuates peripheral inflammation-induced hyperalgesia by inhibiting p38 MAPK in spinal microglia.
    Hua XY; Svensson CI; Matsui T; Fitzsimmons B; Yaksh TL; Webb M
    Eur J Neurosci; 2005 Nov; 22(10):2431-40. PubMed ID: 16307586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A role for proinflammatory cytokines and fractalkine in analgesia, tolerance, and subsequent pain facilitation induced by chronic intrathecal morphine.
    Johnston IN; Milligan ED; Wieseler-Frank J; Frank MG; Zapata V; Campisi J; Langer S; Martin D; Green P; Fleshner M; Leinwand L; Maier SF; Watkins LR
    J Neurosci; 2004 Aug; 24(33):7353-65. PubMed ID: 15317861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spinal microglia initiate and maintain hyperalgesia in a rat model of chronic pancreatitis.
    Liu PY; Lu CL; Wang CC; Lee IH; Hsieh JC; Chen CC; Lee HF; Lin HC; Chang FY; Lee SD
    Gastroenterology; 2012 Jan; 142(1):165-173.e2. PubMed ID: 21963786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fractalkine modulates TNF-alpha secretion and neurotoxicity induced by microglial activation.
    Zujovic V; Benavides J; Vigé X; Carter C; Taupin V
    Glia; 2000 Feb; 29(4):305-15. PubMed ID: 10652441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fractalkine and minocycline alter neuronal activity in the spinal cord dorsal horn.
    Owolabi SA; Saab CY
    FEBS Lett; 2006 Aug; 580(18):4306-10. PubMed ID: 16842787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of p38 mitogen-activated protein kinase in spinal microglia contributes to incision-induced mechanical allodynia.
    Wen YR; Suter MR; Ji RR; Yeh GC; Wu YS; Wang KC; Kohno T; Sun WZ; Wang CC
    Anesthesiology; 2009 Jan; 110(1):155-65. PubMed ID: 19104183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the CX3CR1/p38 MAPK pathway in spinal microglia for the development of neuropathic pain following nerve injury-induced cleavage of fractalkine.
    Zhuang ZY; Kawasaki Y; Tan PH; Wen YR; Huang J; Ji RR
    Brain Behav Immun; 2007 Jul; 21(5):642-51. PubMed ID: 17174525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in spinal cord expression of fractalkine and its receptor in a rat model of disc herniation by autologous nucleus pulposus.
    Park HW; Ahn SH; Kim SJ; Seo JM; Cho YW; Jang SH; Hwang SJ; Kwak SY
    Spine (Phila Pa 1976); 2011 May; 36(12):E753-60. PubMed ID: 21224760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spinal astrocyte and microglial activation contributes to rat pain-related behaviors induced by the venom of scorpion Buthus martensi Karch.
    Jiang F; Liu T; Cheng M; Pang XY; Bai ZT; Zhou JJ; Ji YH
    Eur J Pharmacol; 2009 Nov; 623(1-3):52-64. PubMed ID: 19782067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New evidences for fractalkine/CX3CL1 involved in substantia nigral microglial activation and behavioral changes in a rat model of Parkinson's disease.
    Shan S; Hong-Min T; Yi F; Jun-Peng G; Yue F; Yan-Hong T; Yun-Ke Y; Wen-Wei L; Xiang-Yu W; Jun M; Guo-Hua W; Ya-Ling H; Hua-Wei L; Ding-Fang C
    Neurobiol Aging; 2011 Mar; 32(3):443-58. PubMed ID: 19368990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-6 induces microglial CX3CR1 expression in the spinal cord after peripheral nerve injury through the activation of p38 MAPK.
    Lee KM; Jeon SM; Cho HJ
    Eur J Pain; 2010 Aug; 14(7):682.e1-12. PubMed ID: 19959384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, during acute and chronic inflammation in the rodent CNS.
    Hughes PM; Botham MS; Frentzel S; Mir A; Perry VH
    Glia; 2002 Mar; 37(4):314-27. PubMed ID: 11870871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of microglial P2X7 receptors and downstream signaling pathways in long-term potentiation of spinal nociceptive responses.
    Chu YX; Zhang Y; Zhang YQ; Zhao ZQ
    Brain Behav Immun; 2010 Oct; 24(7):1176-89. PubMed ID: 20554014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced inflammatory and neuropathic pain and decreased spinal microglial response in fractalkine receptor (CX3CR1) knockout mice.
    Staniland AA; Clark AK; Wodarski R; Sasso O; Maione F; D'Acquisto F; Malcangio M
    J Neurochem; 2010 Aug; 114(4):1143-57. PubMed ID: 20524966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of CX3CL1 expression in astrocytes and CX3CR1 in microglia in the spinal cord of a rat model of neuropathic pain.
    Lindia JA; McGowan E; Jochnowitz N; Abbadie C
    J Pain; 2005 Jul; 6(7):434-8. PubMed ID: 15993821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlling pathological pain by adenovirally driven spinal production of the anti-inflammatory cytokine, interleukin-10.
    Milligan ED; Langer SJ; Sloane EM; He L; Wieseler-Frank J; O'Connor K; Martin D; Forsayeth JR; Maier SF; Johnson K; Chavez RA; Leinwand LA; Watkins LR
    Eur J Neurosci; 2005 Apr; 21(8):2136-48. PubMed ID: 15869510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.